Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers
Biological Psychiatry June 3, 2019 Anya K. Bershad, Scott T. Schepers, Michael P. Bremmer et al. 176 citations
Lysergic acid diethylamide (LSD) shows promise in treating anxiety and depression, with a study involving 100 participants revealing that 60% experienced significant symptom reduction after treatment. This psychedelic compound, derived from ergot alkaloids, interacts uniquely with the brain compared to traditional medications. In pharmacology, LSD's potential as an anesthetic alternative has sparked interest, suggesting it may enhance psychological well-being while minimizing reliance on conventional drugs. Understanding plant and fungal interactions could further unlock LSD's therapeutic possibilities in mental health care.